AI labeling rules raise questions for newsrooms

New York and EU policy efforts are pushing AI disclosure into news and public-interest content. The hardest unresolved issue is how to label work shaped by both human judgment and AI systems.

Policymakers are increasingly treating AI labels as a way to reduce confusion and protect audiences from misleading or unattributed content. Research with news audiences in the US found that readers want labels to clarify responsibility, attribution, credibility, trust and personal choice, but they also want details about human involvement, including oversight and the specific tasks AI assisted.

New York’s proposed “fundamental artificial intelligence requirements in (FAIR) news act” would require news media published or disseminated in the state to conspicuously state when content was “substantially created by generative artificial intelligence.” The EU Code of Practice on AI-Generated Content gives deployers reference icons for fully AI generated or AI modified content and implements labeling obligations under the EU AI Act.

The policies differ in scope and trade-offs. New York focuses broadly on news media, while the EU covers AI-generated images, audio, video and public-interest text, with an exception when content has undergone human review or editorial control and an identified person or entity holds responsibility. That leaves unresolved questions around AI-assisted reporting, where both people and systems contribute and where responsibility may not align cleanly with labels or bylines.

54

Impact Score

Rail weighs AI benefits against assurance risks

AI could improve rail operations, safety monitoring and documentation work, but rail deployments need stronger safeguards than generic tools provide. Human validation, traceability and secure handling of sensitive data remain central concerns.

Cisco expands secure AI networking with NVIDIA systems

Cisco is adding NVIDIA-powered switching, unified management, and DPU-based firewall enforcement to support larger AI data center deployments. The portfolio targets enterprises, neoclouds, and sovereign cloud providers building high-performance AI infrastructure.

EU AI Act delay keeps pharma governance pressure in place

The Digital Omnibus agreement gives pharma and biotech companies more time to prepare for high-risk AI obligations, but the core compliance work remains unchanged. US and other non-EU companies may still fall within scope when AI outputs are used in Europe.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.